NR2E3
Basic information
Region (hg38): 15:71792638-71818259
Links
Phenotypes
GenCC
Source:
- retinitis pigmentosa (Supportive), mode of inheritance: AD
- Goldmann-Favre syndrome (Supportive), mode of inheritance: AR
- enhanced S-cone syndrome (Strong), mode of inheritance: AR
- enhanced S-cone syndrome (Strong), mode of inheritance: AR
- retinitis pigmentosa 37 (Strong), mode of inheritance: AD
- enhanced S-cone syndrome (Definitive), mode of inheritance: AR
- retinitis pigmentosa 37 (Definitive), mode of inheritance: AD
- retinitis pigmentosa 37 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Enhanced S-cone syndrome; Retinitis pigmentosa 37 | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 13553271; 11071390; 10655056; 15229190; 17564971; 18294254; 20212206; 21364904; 22605927; 22807301 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (53 variants)
- Enhanced S-cone syndrome (10 variants)
- Retinitis pigmentosa (3 variants)
- Goldmann-Favre syndrome (2 variants)
- Retinal dystrophy (2 variants)
- Retinitis pigmentosa 37 (1 variants)
- Leber congenital amaurosis (1 variants)
- Cone-rod dystrophy (1 variants)
- NR2E3-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NR2E3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 175 | 191 | |||
missense | 13 | 198 | 226 | |||
nonsense | 10 | 12 | 22 | |||
start loss | 3 | |||||
frameshift | 35 | 22 | 58 | |||
inframe indel | 7 | |||||
splice donor/acceptor (+/-2bp) | 13 | 20 | ||||
splice region | 1 | 7 | 26 | 34 | ||
non coding | 28 | 87 | 121 | |||
Total | 54 | 65 | 248 | 271 | 10 |
Highest pathogenic variant AF is 0.0000526
Variants in NR2E3
This is a list of pathogenic ClinVar variants found in the NR2E3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-71810534-C-T | Enhanced S-cone syndrome • Retinitis pigmentosa | Likely benign (Jan 13, 2018) | ||
15-71810605-G-A | Retinitis Pigmentosa, Recessive • Enhanced S-cone syndrome | Uncertain significance (Jun 14, 2016) | ||
15-71810605-G-T | Enhanced S-cone syndrome • Retinitis Pigmentosa, Recessive • Retinitis pigmentosa | Uncertain significance (Jan 13, 2018) | ||
15-71810697-C-T | Retinitis Pigmentosa, Recessive • Enhanced S-cone syndrome | Uncertain significance (Jun 14, 2016) | ||
15-71810734-C-T | Enhanced S-cone syndrome;Retinitis pigmentosa 37 | Uncertain significance (Mar 24, 2017) | ||
15-71810745-T-A | Uncertain significance (Oct 03, 2021) | |||
15-71810745-T-C | Uncertain significance (Aug 27, 2021) | |||
15-71810745-T-G | Enhanced S-cone syndrome | Uncertain significance (Jun 28, 2022) | ||
15-71810748-A-G | Uncertain significance (Sep 27, 2023) | |||
15-71810752-C-T | Uncertain significance (Jun 10, 2022) | |||
15-71810754-G-A | Uncertain significance (Sep 23, 2020) | |||
15-71810766-T-C | Uncertain significance (Nov 13, 2019) | |||
15-71810767-G-A | Retinitis pigmentosa • Enhanced S-cone syndrome | Conflicting classifications of pathogenicity (Dec 03, 2023) | ||
15-71810772-GC-G | Pathogenic (Feb 03, 2022) | |||
15-71810774-T-G | Uncertain significance (Oct 04, 2023) | |||
15-71810778-CA-C | Pathogenic (Nov 17, 2020) | |||
15-71810779-A-G | Likely benign (Apr 06, 2021) | |||
15-71810780-G-T | Enhanced S-cone syndrome | Uncertain significance (Mar 03, 2022) | ||
15-71810782-G-A | Likely benign (Mar 02, 2021) | |||
15-71810788-A-G | Enhanced S-cone syndrome;Retinitis pigmentosa 37 | Likely benign (Jan 11, 2024) | ||
15-71810790-C-T | Goldmann-Favre syndrome | Uncertain significance (Aug 13, 2020) | ||
15-71810793-C-T | Goldmann-Favre syndrome • Inborn genetic diseases | Conflicting classifications of pathogenicity (Nov 17, 2022) | ||
15-71810794-G-A | Enhanced S-cone syndrome • NR2E3-related disorder | Likely benign (Dec 09, 2023) | ||
15-71810793-C-CAG | Pathogenic (Jul 28, 2021) | |||
15-71810795-C-T | Uncertain significance (Aug 19, 2022) |
GnomAD
Source:
dbNSFP
Source:
- Function
- FUNCTION: Orphan nuclear receptor of retinal photoreceptor cells. Transcriptional factor that is an activator of rod development and repressor of cone development. Binds the promoter region of a number of rod- and cone-specific genes, including rhodopsin, M- and S-opsin and rod-specific phosphodiesterase beta subunit. Enhances rhodopsin expression. Represses M- and S-cone opsin expression. {ECO:0000269|PubMed:15689355, ECO:0000269|PubMed:24069298}.;
- Disease
- DISEASE: Enhanced S cone syndrome (ESCS) [MIM:268100]: Autosomal recessive retinopathy in which patients have increased sensitivity to blue light; perception of blue light is mediated by what is normally the least populous cone photoreceptor subtype, the S (short wavelength, blue) cones. ESCS is also associated with visual loss, with night blindness occurring from early in life, varying degrees of L (long, red)- and M (middle, green)-cone vision, and retinal degeneration. {ECO:0000269|PubMed:10655056, ECO:0000269|PubMed:11071390, ECO:0000269|PubMed:12963616, ECO:0000269|PubMed:15459973, ECO:0000269|PubMed:16225923, ECO:0000269|PubMed:18294254, ECO:0000269|PubMed:19006237, ECO:0000269|PubMed:24069298}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 37 (RP37) [MIM:611131]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:17564971, ECO:0000269|PubMed:19006237}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- NHR;Gene expression (Transcription);Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription
(Consensus)
Recessive Scores
- pRec
- 0.523
Haploinsufficiency Scores
- pHI
- 0.646
- hipred
- hipred_score
- ghis
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.986
Mouse Genome Informatics
- Gene name
- Nr2e3
- Phenotype
- vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype;
Zebrafish Information Network
- Gene name
- nr2e3
- Affected structure
- parapineal organ
- Phenotype tag
- abnormal
- Phenotype quality
- has extra parts of type
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;signal transduction;visual perception;phototransduction;negative regulation of cell population proliferation;intracellular receptor signaling pathway;eye photoreceptor cell development;steroid hormone mediated signaling pathway;positive regulation of rhodopsin gene expression;positive regulation of transcription by RNA polymerase II;retina development in camera-type eye
- Cellular component
- nucleus;nucleoplasm;transcription factor complex
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;steroid hormone receptor activity;nuclear receptor activity;zinc ion binding;sequence-specific DNA binding